Steven Bass is Director, Labeling: Global Regulatory Science with Bristol-Myers Squibb, responsible for global labeling for products in clinical development and managing labeling changes to marketed products. He coordinates labeling changes, providing regulatory advice and guidance to the BMS Pharmaceutical Research Institute and the US pharmaceutical marketing divisions. With PhRMA he recently coordinated the BMS responses to FDA’s proposed changes to the US package insert. Dr. Bass held senior regulatory and clinical positions with Clinical Resources Inc., Fujisawa and Fujisawa SmithKline Corporation, Wyeth-Ayerst, and Eastman Pharmaceuticals. He joined BMS in 1988. He is on the DIA Editorial Board and on their Special Interest Advisory Committee for Drug Regulatory Affairs. He is on the faculty of PERI and is Director for the workshop on Regulatory Review of US Prescription Drug Labeling. He received his BS in Pharmacy from Philadelphia College of Pharmacy and Science and his PhD in Pharmacology/Toxicology from Thomas Jefferson University. He did a postdoctoral fellowship in Cardiovascular/Pulmonary Pharmacology at the University of Pennsylvania and has taken additional postgraduate training in Medical Microbiology at Temple Medical School.

Return to Faculty Home